Search
The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...
Megan Moyer is a real estate attorney who assists clients with matters involving property sales and acquisitions, development projects and financings. She also has vast experience advising on leases, having negotiated for millions of square feet of office, medical office, institutional, retail...
Guidance Throughout a Shifting Global Landscape Growth and opportunity are driving factors for success in today’s expanding global economy. The prevalence of crossing borders to gain a competitive edge, sustain profitability, maximize investments or realize personal goals has resulted in a critical...
Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...
Saul Ewing attorneys understand the risks companies and individuals face when their intellectual property and brand are threatened, and we have deep experience helping clients protect their IP rights when disputes escalate to litigation. Our attorneys handle a variety of IP litigation cases across a...
Growth and opportunity are driving factors behind today’s global landscape. The prevalence of crossing borders to gain a competitive edge, sustain profitability, or realize personal goals has resulted in a critical need for immigration counsel. Whether it is a multinational corporation, a start-up...
With more than 20 years of experience, Julian Montero represents clients in their general business and transactional matters, including corporate structuring, business planning, mergers and acquisitions, cross-border transactions and finance matters and he regularly advises foreign investors on...
Diane Nobile advises international clients, high net worth families, real estate investors and companies on pre-immigration tax planning, investing in U.S. real estate and lending, corporate formation and governance. With a concentration on international taxation, real estate and corporate law...
Saul Ewing’s Litigation Department features approximately 200 attorneys across 18 offices. We handle a wide range of matters including complex business and commercial disputes, bet-the-company legal proceedings, and high-profile cases in state and federal courts and Alternative Dispute Resolution...
Saul Ewing’s Shareholder Litigation Practice is national, but we have substantial strength in Maryland. It is the second most popular state of incorporation for companies listed on the New York Stock Exchange and the state in which more than 80 percent of all publicly registered REITs are formed...
Comprehensive Guidance for Seizing and Optimizing Investments in Opportunity Zones In 2017, Congress created significant tax incentives for investment in Opportunity Zones. An investor who has recognized capital gains and makes a timely investment in a "Qualified Opportunity Fund" may (1) defer the...
Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...
Erik Williams assists clients with commercial real estate transactions, with an emphasis on site acquisition, disposition, finance, construction, and leasing matters. He has advised a broad range of public and private clients, from small entrepreneurs to large institutions. Erik also represents...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Jim Taylor is a trial lawyer with first-chair experience handling complex litigation in federal and state courts. A significant portion of his practice uses that litigation experience and perspective to counsel clients in managing high-profile crises, minimizing financial and reputational risks...
Rick Carroll advises domestic companies and international clients with business interests in the United States on a variety of transactions and corporate governance matters, including mergers, and acquisitions, stock purchases, asset sales, conversions and domestications, and dissolutions. In...
Jay M. Rosen focuses his practice in general corporate and securities law. He has represented both public and private companies in connection with mergers and acquisitions, public and private offerings of securities and SEC disclosure, as well as corporate governance, debt and equity financing and...
Anthony Kang represents companies and individuals in various business matters and real estate transactions. Anthony has considerable experience handling the acquisition and disposition of commercial and multi-family properties, representing lenders and borrowers in real estate financing, and...
Sally Michael has extensive experience representing owners and developers on acquisitions, dispositions, financings, development, and leasing of all classes of commercial property. Sally also represents borrowers and lenders on restructurings and workouts of distressed debt. She is lead counsel on...